Prescription drug · ANDA
Acyclovir NDC 51407-852
Acyclovir 200 mg/1 · Capsule · Oral · Golden State Medical Supply, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51407-852-01 | 51407085201 | 100 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-01)Marketed from Nov 16, 2023 | |
| 51407-852-05 | 51407085205 | 500 CAPSULE in 1 BOTTLE, PLASTIC (51407-852-05)Marketed from Nov 16, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acyclovir
- Generic name (nonproprietary)
- acyclovir
- Active ingredients
- Acyclovir — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206261
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 51407-852_235e8aee-fc79-b9bc-e063-6394a90a8e34SPL ID 235e8aee-fc79-b9bc-e063-6394a90a8e34SPL set ID 0d99ba77-c3c5-1fd0-e063-6294a90a6f2aRxCUI 197310UNII X4HES1O11F
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451407085201followed by a unit qualifier and the quantityPackage 51407-0852-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Herpes Zoster Infections : Acyclovir is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes : Acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox : Acyclovir is indicated for the treatment of chickenpox (varicella).
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 206261
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Proficient Rx LP | 71205-578 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-1290 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Carlsbad Technology, Inc. | 61442-114 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | NuCare Pharmaceuticals,Inc. | 68071-2299 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 63629-2009 |